Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
J Ethnopharmacol ; 210: 372-385, 2018 Jan 10.
Article in English | MEDLINE | ID: mdl-28887215

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: In the Peruvian Amazon, the use of medicinal plants is a common practice. However, there is few documented information about the practical aspects of their use and few scientific validation. The starting point for this work was a set of interviews of people living in rural communities from the Peruvian Amazon about their uses of plants. Protozoan diseases are a public health issue in the Amazonian communities, who partly cope with it by using traditional remedies. Validation of these traditional practices contributes to public health care efficiency and may help identify new antiprotozoal compounds. AIMS OF STUDY: to inventory and validate the use of medicinal plants by rural people of Loreto region. MATERIALS AND METHODS: Rural mestizos were interviewed about traditional medication of parasite infections with medicinal plants. Ethnopharmacological surveys were undertaken in two villages along Iquitos-Nauta road (Loreto region, Peru), namely 13 de Febrero and El Dorado communities. Forty-six plants were collected according to their traditional use for the treatment of parasitic diseases, 50 ethanolic extracts (different parts for some of the plants) were tested in vitro on Plasmodium falciparum (3D7 sensitive strain and W2 chloroquine resistant strain), Leishmania donovani LV9 strain and Trypanosoma brucei gambiense. Cytotoxic assessment (HUVEC cells) of the active extracts was performed. Two of the most active plants were submitted to preliminary bioguided fractionation to ascertain and explore their activities. RESULTS: From the initial plants list, 10 were found to be active on P. falciparum, 15 on L. donovani and 2 on the three parasites. The ethanolic extract from Costus curvibracteatus (Costaceae) leaves and Grias neuberthii (Lecythidaceae) bark showed strong in vitro activity on P. falciparum (sensitive and resistant strain) and L. donovani and moderate activity on T. brucei gambiense. CONCLUSIONS: The Amazonian forest communities in Peru represents a source of knowledge on the use of medicinal plants. In this work, several extracts with antiprotozoal activity were identified. This work contributes to validate some traditional uses and opens subsequent investigations on active compounds isolation and identification.


Subject(s)
Antiprotozoal Agents/pharmacology , Medicine, Traditional/methods , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Animals , Antiprotozoal Agents/isolation & purification , Cricetinae , Ethnopharmacology , Female , Human Umbilical Vein Endothelial Cells , Humans , Leishmania donovani/drug effects , Parasitic Sensitivity Tests , Peru , Plant Extracts/isolation & purification , Plasmodium falciparum/drug effects , Protozoan Infections/drug therapy , Protozoan Infections/parasitology , Rural Population , Surveys and Questionnaires , Trypanosoma brucei gambiense/drug effects
2.
Nat Prod Res ; 30(11): 1320-6, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26222897

ABSTRACT

The threatened Brazilian Cerrado biome is an important biodiversity hotspot but still few explored that constitutes a potential reservoir of molecules to treat infectious diseases. We selected eight Cerrado plant species for screening against the erythrocytic stages of Plasmodium falciparum, human intracellular stages of Trypanosoma cruzi and bloodstream forms of T. brucei gambiense, and for their cytotoxicity upon the rat L6-myoblast cell line. Bioassays were performed with 37 hexane, ethyl acetate and ethanol extracts prepared from different plant organs. Activities against parasites were observed for 24 extracts: 9 with anti-P. falciparum, 4 with anti-T. cruzi and 11 with anti-T. brucei gambiense activities. High anti-protozoal activity (IC50 values < 10 µg/mL) without obvious cytotoxicity to L6 cells was observed for eight extracts from plants: Connarus suberosus, Blepharocalyx salicifolius, Psidium laruotteanum and Myrsine guianensis. Overall, studies of plant extracts will contribute to increase the biodiversity knowledge essential for Cerrado conservation and sustainable development.


Subject(s)
Antiprotozoal Agents/isolation & purification , Ecosystem , Plant Extracts/pharmacology , Animals , Antiprotozoal Agents/pharmacology , Biodiversity , Brazil , Cell Line , Grassland , Humans , Plasmodium falciparum/drug effects , Rats , Trypanosoma brucei gambiense/drug effects , Trypanosoma cruzi/drug effects
3.
Parasitol Res ; 104(2): 223-8, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18787843

ABSTRACT

Tubercidin (TUB) is an adenosine analog with potent antiparasite action, unfortunately associated with severe host toxicity. Prevention of TUB toxicity can be reached associating nitrobenzylthioinosine (NBMPR), an inhibitor of the purine nucleoside transport, specifically target to the mammal cells. It was demonstrated that this nucleoside transport inhibitor has no significant effect in the in vitro uptake of TUB by Schistosoma mansoni and Trypanosoma gambiense. Seeking to evaluate if the association of these compounds is also effective against leishmania, we analyzed the TUB-NBMPR combined treatment in in vitro cultures of promastigote forms of Leishmania (L.) amazonensis, Leishmania (L.) chagasi, Leishmania (L.) major, and Leishmania (V.) braziliensis as well as in cultures of amastigote forms of L. (L.) amazonensis, mice macrophages infected with L. (L.) amazonensis, and in vivo tests in BALB/c mice infected with L. (L.) amazonensis. We demonstrated that TUB-NBMPR combined treatment can be effective against leishmania cells protecting mammalian cells from TUB toxicity.


Subject(s)
Antiparasitic Agents/therapeutic use , Enzyme Inhibitors/therapeutic use , Leishmania/drug effects , Leishmaniasis/drug therapy , Thioinosine/analogs & derivatives , Thionucleotides/therapeutic use , Tubercidin/therapeutic use , Animals , Antiparasitic Agents/pharmacology , Antiparasitic Agents/toxicity , Cells, Cultured , Drug Therapy, Combination , Enzyme Inhibitors/pharmacology , Macrophages/drug effects , Macrophages/parasitology , Mice , Mice, Inbred BALB C , Schistosoma mansoni/drug effects , Thioinosine/pharmacology , Thioinosine/therapeutic use , Thionucleotides/pharmacology , Trypanosoma brucei gambiense/drug effects , Tubercidin/pharmacology , Tubercidin/toxicity
4.
J Parasitol ; 80(6): 924-30, 1994 Dec.
Article in English | MEDLINE | ID: mdl-7799165

ABSTRACT

Resistance to lysis by human serum (HS) is an important parameter used to distinguish Trypanosoma brucei brucei from both Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Neither the exact nature of the trypanolytic factor (TLF) nor the mechanism of action by which HS lyses susceptible trypanosomes is well understood. This report tries to elucidate the role played by the variable surface glycoprotein (VSG) coat and trypanosome surface-related processes in the mechanism of HS lysis of HS-sensitive (HSS) and HS-resistant (HSR) trypanosomes. Procyclic forms of T. brucei gambiense transformed from either HSS or HSR bloodstream stages were found to be HSR. These procyclic forms were shown to have lost their VSG coat. However, the addition of excess soluble VSG from HSS trypanosomes did not block lysis of HSS trypanosomes. Human serum lysis was significantly inhibited if the trypanosomes were incubated with membrane stabilizers, i.e., including cytochalasins (B, D, and E specifically), zinc acetate, vinblastine, and benzyl alcohol, or with the lysosomotropic agents ammonium chloride and chloroquine. The inhibition exerted by these compounds was always reversible. The results in this report, taken together, strengthen the hypothesis that the lytic factor interacts with and moves along the trypanosome surface to be internalized eventually.


Subject(s)
Blood/immunology , Trypanosoma brucei gambiense/immunology , Ammonium Chloride/pharmacology , Animals , Benzyl Alcohol , Benzyl Alcohols/pharmacology , Chloroquine/pharmacology , Complement System Proteins/immunology , Cytochalasins/pharmacology , Mice , Mice, Inbred C3H , Sulfates/pharmacology , Trypanosoma brucei gambiense/drug effects , Variant Surface Glycoproteins, Trypanosoma/immunology , Vinblastine/pharmacology , Zinc Compounds/pharmacology , Zinc Sulfate
SELECTION OF CITATIONS
SEARCH DETAIL